BSE Live
Feb 10, 09:00Prev. Close
1510.40
Open Price
0.00
Bid Price (Qty.)
1491.00 (1)
Offer Price (Qty.)
1510.50 (3)
NSE Live
Feb 09, 15:51Prev. Close
1509.50
Open Price
1509.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Hester Biosciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 33.89 | 24.88 | 32.96 | 46.41 | 40.79 | |
| Diluted EPS (Rs.) | 33.89 | 24.88 | 32.96 | 46.41 | 40.79 | |
| Cash EPS (Rs.) | 48.82 | 39.65 | 52.10 | 65.41 | 56.44 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 369.41 | 356.03 | 339.19 | 314.32 | 277.37 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 369.41 | 356.03 | 339.19 | 314.32 | 277.37 | |
| Revenue from Operations/Share (Rs.) | 365.70 | 357.99 | 312.79 | 276.25 | 251.95 | |
| PBDIT/Share (Rs.) | 76.38 | 75.58 | 77.30 | 86.66 | 86.21 | |
| PBIT/Share (Rs.) | 56.63 | 55.39 | 52.97 | 67.17 | 70.56 | |
| PBT/Share (Rs.) | 41.70 | 32.14 | 42.02 | 62.39 | 58.90 | |
| Net Profit/Share (Rs.) | 29.07 | 19.46 | 27.77 | 45.92 | 40.79 | |
| NP After MI And SOA / Share (Rs.) | 32.31 | 22.20 | 31.30 | 46.41 | 40.47 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 20.88 | 21.11 | 24.71 | 31.37 | 34.21 | |
| PBIT Margin (%) | 15.48 | 15.47 | 16.93 | 24.31 | 28.00 | |
| PBT Margin (%) | 11.40 | 8.97 | 13.43 | 22.58 | 23.37 | |
| Net Profit Margin (%) | 7.94 | 5.43 | 8.87 | 16.62 | 16.18 | |
| NP After MI And SOA Margin (%) | 8.83 | 6.20 | 10.00 | 16.80 | 16.06 | |
| Return on Networth/Equity (%) | 8.74 | 6.47 | 9.51 | 15.18 | 15.08 | |
| Return on Capital Employed (%) | 9.12 | 8.46 | 8.64 | 12.28 | 17.16 | |
| Return on Assets (%) | 4.20 | 2.85 | 3.97 | 7.02 | 8.37 | |
| Total Debt/Equity (X) | 0.66 | 0.82 | 0.96 | 0.86 | 0.38 | |
| Asset Turnover Ratio (%) | 0.47 | 0.46 | 0.43 | 0.53 | 52.14 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 1.56 | 2.03 | 1.53 | 2.01 | 2.63 | |
| Quick Ratio (X) | 1.00 | 1.31 | 0.96 | 1.23 | 1.62 | |
| Inventory Turnover Ratio (X) | 4.26 | 0.68 | 0.66 | 0.53 | 3.44 | |
| Dividend Payout Ratio (NP) (%) | 18.56 | 36.02 | 31.94 | 21.54 | 16.30 | |
| Dividend Payout Ratio (CP) (%) | 11.52 | 18.86 | 17.97 | 15.17 | 11.76 | |
| Earnings Retention Ratio (%) | 81.44 | 63.98 | 68.06 | 78.46 | 83.70 | |
| Cash Earnings Retention Ratio (%) | 88.48 | 81.14 | 82.03 | 84.83 | 88.24 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 5.12 | 3.25 | 7.06 | 18.14 | 9.09 | |
| Interest Coverage Ratios (Post Tax) (%) | 5.12 | 3.25 | 7.06 | 18.14 | 9.09 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 1,279.65 | 1,416.65 | 1,555.60 | 2,514.68 | 1,703.08 | |
| EV/Net Operating Revenue (X) | 4.11 | 4.65 | 5.85 | 10.70 | 7.95 | |
| EV/EBITDA (X) | 19.69 | 22.03 | 23.66 | 34.11 | 23.22 | |
| MarketCap/Net Operating Revenue (X) | 3.43 | 3.88 | 4.86 | 9.83 | 7.61 | |
| Retention Ratios (%) | 81.43 | 63.97 | 68.05 | 78.45 | 83.69 | |
| Price/BV (X) | 3.39 | 4.05 | 4.62 | 8.88 | 7.14 | |
| Price/Net Operating Revenue | 3.43 | 3.88 | 4.86 | 9.83 | 7.61 | |
| Earnings Yield | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
03.02.2026
Hester Bio Consolidated December 2025 Net Sales at Rs 77.42 crore, up 22.46% Y-o-Y
03.02.2026
Hester Bio Standalone December 2025 Net Sales at Rs 70.35 crore, up 11.98% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y
03.02.2026
Hester Bio Consolidated December 2025 Net Sales at Rs 77.42 crore, up 22.46% Y-o-Y
03.02.2026
Hester Bio Standalone December 2025 Net Sales at Rs 70.35 crore, up 11.98% Y-o-Y
19.11.2025
Hester Bio Consolidated September 2025 Net Sales at Rs 70.97 crore, down 15.2% Y-o-Y
18.11.2025
Hester Bio Standalone September 2025 Net Sales at Rs 64.58 crore, down 12.14% Y-o-Y